Avecho Biotech Limited (AVE)
20mins delayed
Movement
1 Year Return
Avecho Biotech Limited Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $6.31 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
AVE Statistics
24 January
1,988 / 2,295
ASX Size Rank
1yr Return
vs Sector (1yr)
-46.89%
vs ASX 200 (1yr)
-20.88%
$6.31 million
Market Cap
Share Issue
1.58 billion
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
24 January
20
PE Ratio
EPS ($)
-
Earnings Yield
5.00%
NTA ($)
-
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Avecho Biotechnology Limited (AVE , formerly Phosphagenics Limited) is a research-based biotechnology company that discovers and develops new ways to enhance the delivery, effectiveness, and/or tolerability of proven pharmaceutical, consumer and animal health products.
Former Names
Vital Capital Limited (VIT), 9/2/2004; Greenchip Development Capital Limited (GDC), 27/04/1999; Phosphagenics Limited (POH
), 24/05/2019
Upcoming Calendar
| 27 Feb 2020 | Report (Prelim) |
| 25 Mar 2020 | Report (Annual) |
| 28 Aug 2020 | Report (Interim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
AVE is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Dr Gregory (Greg) Collier | Executive Chairman, Executive Director | Apr 2017 |
|
| Mr David Segal | Non-Executive Director | May 2016 |
|
| Dr Ross Murdoch | Non-Executive Director | Apr 2015 |
|
| Mr Matthew Patrick McNamara | Non-Executive Director | Jan 2020 |
|
| Melanie Jaye Leydin | Chief Financial Officer, Company Secretary | N/A | |
| Paul Gavin | Chief Scientific Officer | N/A | |
| Roksan Libinaki | General Manager, Animal Health and Nutrition | N/A |
Director Transactions
AVE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
There are no director transactions for code AVE in our database.
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 459 | 913 | 690 | 2,165 | 1,297 | 5,524 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 84,810,166 | 5.38% |
| Mr Mark Gregory Kerr (Lindmark Inv Staff S/F A/C) | 67,153,797 | 4.26% |
| Mr Mark Gregory Kerr + Mrs Linda Marie Kerr (Lindmark Inv Staff S/F A/C) | 59,179,837 | 3.75% |
| BNP Paribas Noms Pty Ltd (DRP) | 42,257,490 | 2.68% |
| Paradyce Pty Ltd (The Paradyce A/C) | 38,600,000 | 2.45% |
| Rosscope Pty Ltd (Ross Copeland Family A/C) | 30,558,184 | 1.94% |
| Mr Ross Copeland + Mrs Gina Copeland | 23,018,212 | 1.46% |
| ACK Pty Ltd (Markoff Super No 2 A/C) | 20,494,147 | 1.30% |
| Kazakco Pty Ltd (Kent Family A/C) | 20,000,000 | 1.27% |
| Citicorp Nominees Pty Limited | 19,641,482 | 1.25% |
| Mr Ross Graham Copeland + Mrs Gina Copeland (Publicity Press S/F A/C) | 16,868,545 | 1.07% |
| Mr Brandon Armon Batagol | 16,005,597 | 1.01% |
| Dr Maurice Arthur Trewhella + Mrs Elizabeth Trewhella (Simpetejen Super Fund A/C) | 16,000,000 | 1.01% |
| Citycastle Pty Ltd | 15,600,000 | 0.99% |
| BHL Pension Pty Ltd (BHL Pension Fund A/C) | 15,000,000 | 0.95% |
| J P Morgan Nominees Australia Pty Limited | 13,523,788 | 0.86% |
| Gold Road Orient Holdings Pty Ltd | 12,500,000 | 0.79% |
| Mr David Segal | 11,000,000 | 0.70% |
| SSDG Pty Ltd (SSDG Super Fund A/C) | 11,000,000 | 0.70% |
| Mr Gary Dean Shaw | 11,000,000 | 0.70% |
| All other shareholders | 65.48 % | |
The Top 20 Shareholders of AVE hold 34.52% of shares on issue.
AVE Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
AVE Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Development, production, sale and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skin care and animal health and nutrition industries.
Incorporated: in VIC on 19/06/1992 as Greenchip Development Capital Ltd. Name changed to Vital Capital Limited on 27/04/1999. Name changed to Phosphagenics Limited on 10/2/2004. Changed GICS from 4020 Diversified Financials to 3520 Pharmaceuticals & Biotechnology on 4/3/2005.
Unit A8, 2A Westall Rd
Clayton VIC 3168
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.